RNS Number : 1070V Renalytix PLC 09 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of
RNS Number : 9024U Renalytix PLC 08 December 2021 Renalytix plc (" Renalytix " or the " Company ") Director/PDMR Dealing New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,
RNS Number : 7546U Renalytix PLC 07 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022 LONDON and SALT LAKE CITY , December 7, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial
NEW YORK and SALT LAKE CITY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will release first quarter fiscal year 2022 financial results on Tuesday, December 7, 2021, before market open. The Company will host a corresponding conference call
RNS Number : 2978U Renalytix PLC 02 December 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 LONDON and SALT LAKE CITY , December 2, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the
RNS Number : 0262T Renalytix PLC 19 November 2021 Renalytix plc ("Renalytix" or the "Company") Publication of Annual Report 2021 and Notice of 2021 Annual General Meeting LONDON and SALT LAKE CITY , November 19, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease NEW YORK and SALT LAKE CITY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- In recognition of National Diabetes Month and concurrent with the launch of KidneyIntelX in the Veterans
RNS Number : 8663R Renalytix PLC 10 November 2021 Renalytix plc ("Renalytix" or the "Company") Renalytix Convenes Expert Panel at VA Healthcare Summit Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease NEW
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- St. Joseph's Health and Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced a partnership to implement an
